AmerisourceBergen Corporation, now known as Cencora, Inc. (NYSE: COR), is one of the world’s largest pharmaceutical sourcing and distribution companies, generating over $321 billion in annual revenue and operating in 50+ countries. Steven H. Collis served as President & CEO from 2011 to 2024, and as Chairman from 2016, guiding the company through a period of extraordinary growth. Under Collis’s leadership, AmerisourceBergen expanded from a domestic drug distributor into a global healthcare solutions leader, completing transformative acquisitions including World Courier, PharMEDium, and the $6.5 billion purchase of Alliance Healthcare. Collis also oversaw the company’s rebranding to Cencora in August 2023 before transitioning to Executive Chairman in October 2024.

(Suggested: McKesson CEO Email & Net Worth – John Hammergren)

Steven Collis – Quick Facts

AmerisourceBergen (Cencora) Competitors

Cencora (formerly AmerisourceBergen) operates in the highly concentrated pharmaceutical distribution industry. Together with McKesson and Cardinal Health, these “Big Three” control over 90% of the U.S. drug distribution market. Key competitors include:

• McKesson Corporation – largest U.S. healthcare distributor (~41% market share)
• Cardinal Health – third-largest drug wholesaler (~24% market share)
• Henry Schein – global healthcare products distributor
• Owens & Minor – medical product manufacturing and distribution
• Express Scripts (Cigna) – pharmacy benefit management rival
• Morris & Dickson – independent pharmaceutical wholesaler
• Medline Industries – medical supply manufacturer and distributor

Steven Collis Net Worth 2026 – AmerisourceBergen CEO Salary

As of 2026, Steven Collis net worth is estimated at approximately $95–100 million USD, based on SEC insider filings. As of October 2025, Collis owned approximately 305,913 shares of Cencora (COR) stock valued at over $97 million. Over the past 18 months, he executed 17 insider transactions with a net sale of 301,699 shares, including a notable 31,350-share sale in September 2025 worth approximately $9 million.

AmerisourceBergen CEO Compensation Breakdown (FY2024)

Steven Collis’s total compensation for fiscal year 2024 (ended September 30, 2024) was approximately $18.5 million. Note that he served as CEO for the first 12 months of the fiscal year and transitioned to Executive Chairman effective October 1, 2024.

Cencora Net Worth 2026 – Is Cencora Profitable?

Yes, Cencora (formerly AmerisourceBergen) is a highly profitable company and one of the largest in the world by revenue. For fiscal year 2025 (ended September 30, 2025), the company reported $321.3 billion in revenue and $1.6 billion in GAAP net income. Cencora currently has a market capitalization of approximately $70 billion and is ranked in the top 10 on the Fortune 500.

Cencora Financial Summary (FY2025)

(Recommended: Cardinal Health CEO Email & Net Worth – Michael Kaufmann)

AmerisourceBergen CEO Email Address | Steven Collis Contact

Below are the contact details and social media profiles associated with former AmerisourceBergen/Cencora CEO Steven H. Collis. Note that since Collis retired from Cencora in October 2025, his corporate email may no longer be active.

Career & Education – Company, University, & College

Steven H. Collis built a career spanning more than three decades in pharmaceutical distribution and healthcare services. Born and raised in South Africa, he began his professional life in finance before transitioning to the pharmaceutical industry, ultimately becoming one of the longest-serving CEOs in the Fortune 10.

Steven Collis Career Timeline

Steven Collis began his career as an accountant at KPMG in South Africa. In 1987, he joined Merck & Co., where he held a series of finance and operational roles in both South Africa and the United States. Collis came to America in 1988 and helped found what would become AmerisourceBergen’s Specialty Group in 1994, a pioneering business focused on specialty pharmaceutical distribution.

He rose through the ranks at AmerisourceBergen, serving as SVP and President of the Specialty Group (2001–2007), EVP and President of the Specialty Group (2007–2009), EVP and President of AmerisourceBergen Drug Corporation (2009–2010), and President and COO (2010–2011). In July 2011, he succeeded R. David Yost as President and CEO, and was elected Chairman in 2016.

(Related: CVS CEO Email & Net Worth – Karen Lynch Salary)

Under Collis’s leadership, AmerisourceBergen completed several transformative acquisitions, including World Courier (specialty logistics), MWI Veterinary Supply, PharMEDium (compounding pharmacy), and the landmark $6.5 billion acquisition of Alliance Healthcare in 2021, which expanded the company’s international footprint to 50+ countries. He also oversaw the company’s rebranding from AmerisourceBergen to Cencora in August 2023. Collis transitioned to Executive Chairman in October 2024 and stepped down from the board in October 2025.

Education

Steven Collis Wiki – Age, Wife, Family, & More

Steven H. Collis (age 64–65, born 1961) was raised in South Africa. He emigrated to the United States in 1988. His wife is Toni Collis and they have three children: two daughters, Michala and Olivia, and one son, Jordan. Collis is known as a friendly, approachable leader. His favorite sport is rugby, and he enjoys pasta and sushi. In his free time, the family enjoys traveling — they have visited Thailand, Africa, Peru, Israel, and the Galapagos Islands. He describes himself as a beach person, though the rest of the family prefers excursion trips.

Notable Achievements & Recognitions

• HDA Nexus Award for Lifetime Achievement – Honored by the Healthcare Distribution Alliance Research Foundation in September 2024
• Fortune 10 CEO – Led one of the 10 largest U.S. companies by revenue for over a decade
• Business Roundtable Member – Active member shaping U.S. business and public policy
• CECP Board of Directors – Joined the Board of Chief Executives for Corporate Purpose in 2025
• Global Expansion Architect – Oversaw the $6.5 billion Alliance Healthcare acquisition, expanding to 50+ countries
• Cencora Rebrand – Led the company’s transformation from AmerisourceBergen to Cencora in 2023

Collis is recognized as a philanthropic leader with strong ties to the healthcare community. He served on the board of the Healthcare Distribution Alliance and was actively involved in industry advocacy throughout his career.

(Suggested: CVS Health CEO – Larry Merlo)

About Cencora (formerly AmerisourceBergen)

Cencora, Inc. (NYSE: COR), formerly known as AmerisourceBergen Corporation, is an American multinational pharmaceutical sourcing and distribution services company headquartered in Conshohocken, Pennsylvania. Founded in 2001 through the merger of AmeriSource Health Corporation and Bergen Brunswig Corporation, the company is one of the largest enterprises in the world by revenue.

Cencora operates in over 50 countries with more than 46,000 employees worldwide. The company reported $321.3 billion in revenue for fiscal year 2025, making it one of the top 10 companies on the Fortune 500. It trades on the New York Stock Exchange under the ticker symbol COR, with a market capitalization of approximately $70 billion as of February 2026.

Frequently Asked Questions (FAQ)

Who is the current CEO of AmerisourceBergen (Cencora)?

The current CEO of Cencora (formerly AmerisourceBergen) is Robert P. Mauch, who was appointed President and Chief Executive Officer on October 1, 2024. He succeeded Steven H. Collis, who served as CEO from 2011 to 2024 and transitioned to Executive Chairman before retiring from the board in October 2025.

What is Steven Collis’s net worth in 2026?

As of 2026, Steven Collis’s net worth is estimated at approximately $95–100 million USD, primarily based on his Cencora (COR) stock holdings. As of October 2025, he owned approximately 305,913 shares of COR stock valued at over $97 million, according to SEC insider trading filings.

What was AmerisourceBergen CEO’s salary?

Steven Collis’s total compensation for fiscal year 2024 was approximately $18.5 million, including a $1.46 million base salary, $4.1 million annual bonus, $12.5 million in stock awards, and $408,225 in other compensation. Over his decade-plus tenure, his average annual compensation exceeded $12 million per year.

What is AmerisourceBergen CEO’s email address?

Steven Collis’s former corporate email address was [email protected]. Since he retired from Cencora in October 2025, this email may no longer be active. He can be reached on Twitter/X at @SteveCollis_ABC or via LinkedIn. For general inquiries, call Cencora customer service at 1-888-711-5469.

Why did AmerisourceBergen change its name to Cencora?

AmerisourceBergen rebranded to Cencora in August 2023 to better reflect its evolution from a U.S. pharmaceutical distributor into a global healthcare company. The name “Cencora” combines the Latin root “cen” (meaning “new” or “fresh”) with “cor” (meaning “heart”), symbolizing the company’s commitment to creating healthier futures. The stock ticker changed from ABC to COR.

Is Cencora (AmerisourceBergen) a profitable company?

Yes, Cencora is highly profitable. In fiscal year 2025 (ended September 30, 2025), the company reported GAAP net income of $1.6 billion on revenue of $321.3 billion. GAAP operating income grew 20.8% year-over-year to $2.6 billion, and adjusted diluted EPS increased 16.3% to $16.00. The company has a market cap of approximately $70 billion.

Article last updated:January 2026March 2, 2026